Home/Filings/4/A/0001654954-23-009593
4/A//SEC Filing

Lemieux Stephen 4/A

Accession 0001654954-23-009593

CIK 0001540159other

Filed

Jul 23, 8:00 PM ET

Accepted

Jul 24, 4:45 PM ET

Size

5.3 KB

Accession

0001654954-23-009593

Insider Transaction Report

Form 4/AAmended
Period: 2023-07-20
Lemieux Stephen
Chief Financial Officer
Transactions
  • Award

    Share Option (right to buy)

    2023-07-20+75,00075,000 total
    Exercise: $0.83Exp: 2033-07-20Common Shares (75,000 underlying)
Footnotes (1)
  • [F1]This option vests monthly in equal proportions over 36 months beginning on the date of grant.

Documents

1 file

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother

Related Parties

1
  • filerCIK 0001983036

Filing Metadata

Form type
4/A
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:45 PM ET
Size
5.3 KB